Although electrochemical and optical biosensors have taken over the bulk of the scientific literature and the commercial market, it is necessary for the scientific audience to be exposed to other sensing methodologies associated with cervical cancer diagnosis. Subsequently, the scientific principles behind ...
摘要: ed from Obstet Gynecol 2023;142(5):1036–1043) Cervical cancer screening has saved millions of lives over the past 7 decades. Never-screened or underscreened women currently account for more than half of all cervical cancer cases in the United States....
Identification of HPV infection as the etiologic agent of virtually all cases of cervical cancer, as well as a proportion of other epithelial cancers, has led to development of three FDA-approved multivalent prophylactic HPV vaccines composed of virus-like particles (VLPs). This essay describes the...
In Africa, cervical cancer is one of the most prevalent cancers among women of reproductive age (15-49 years) [1]. This cancer is caused by two types of human papillomavirus (HPV) strands (16 and 18) that are responsible for over 70% of precancerous lesions [2]. According to the WHO...
Cervical cancer precursors: cytohistologic correlation with the results of HPV testing Persistence of high-risk types of human papillomavirus (HPV) is responsible for the development, maintenance and progression of squamous intraepithelial lesions (SILs). Cytohistologic correlation with the results of the...
Sacituzumab govitecan (SG) is an antibody–drug conjugate composed of an antibody with affinity for Trop-2 coupled to SN-38 via hydrolyzable linker. SG is approved for patients with metastatic triple-negative breast cancer (mTNBC) who have received two or more prior chemotherapies (at least ...
Click to launch & play an online audio visual presentation by Dr. John Schiller on HPV vaccines to prevent cervical cancer and other HPV-associated diseases, part of a collection of multimedia lectures.
Human papillomavirus (HPV) is closely associated with cervical cancer that the incidence of this tumor is regarded as a surrogate marker for HPV infection ... H Gelband,P Jha,R Sankaranarayanan,... 被引量: 18发表: 2015年 HPV, cervical cancer, vaccine 18 vaccination could be very cost-effec...
'Worse than HIV' or 'not as serious as other diseases'? Conceptualization of cervical cancer among newly screened women in Zambia 喜欢 0 阅读量: 25 作者:White,H.L.,Mulambia,Sinkala,Mwanahamuntu,M.H.,Parham,G.P.,Moneyham,Grimley,D.M.,Chamot ...
The targets are aspirational and as yet, it appears no country has been verified as reaching them. The aim is for call countries to reach a target of cervical cancer incidence of less than four cases per 100,000 women per year, eliminating it as a public health threat. However, a present...